142 related articles for article (PubMed ID: 34591174)
1. Autoimmune retinopathy: clinical, electrophysiological, and immunological features in nine patients with long-term follow-up.
Safadi K; Chowers I; Banin E; Rosin B; Tiosano L; Amer R
Graefes Arch Clin Exp Ophthalmol; 2022 Mar; 260(3):975-991. PubMed ID: 34591174
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Retinal Structural and Functional Characteristics in Eyes with Autoimmune Retinopathy.
Sepah YJ; Sadiq MA; Hassan M; Hanout M; Soliman M; Agarwal A; Afridi R; Coupland SG; Nguyen QD
Curr Mol Med; 2015; 15(6):578-86. PubMed ID: 26238366
[TBL] [Abstract][Full Text] [Related]
3. Non-paraneoplastic autoimmune retinopathy that developed in fellow eye 10 years after onset in first eye: a case report.
Miura G; Baba T; Iwase T; Ohde H; Kanda A; Saito W; Ishida S; Yamamoto S
BMC Ophthalmol; 2020 Apr; 20(1):132. PubMed ID: 32252709
[TBL] [Abstract][Full Text] [Related]
4. Clinical Features of Japanese Patients With Anti-α-enolase Antibody-Positive Autoimmune Retinopathy: Novel Subtype of Multiple Drusen.
Ando R; Saito W; Kanda A; Kase S; Fujinami K; Sugahara M; Nakamura Y; Eguchi S; Mori S; Noda K; Shinoda K; Ishida S
Am J Ophthalmol; 2018 Dec; 196():181-196. PubMed ID: 30195891
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune retinopathies: a report of 3 cases.
Oray M; Kir N; Tuncer S; Onal S; Tugal-Tutkun I
Ocul Immunol Inflamm; 2013 Dec; 21(6):424-33. PubMed ID: 23730997
[TBL] [Abstract][Full Text] [Related]
6. Hyperautofluorescent ring in autoimmune retinopathy.
Lima LH; Greenberg JP; Greenstein VC; Smith RT; Sallum JM; Thirkill C; Yannuzzi LA; Tsang SH
Retina; 2012 Jul; 32(7):1385-94. PubMed ID: 22218149
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomography findings in autoimmune retinopathy.
Abazari A; Allam SS; Adamus G; Ghazi NG
Am J Ophthalmol; 2012 Apr; 153(4):750-6, 756.e1. PubMed ID: 22245461
[TBL] [Abstract][Full Text] [Related]
8. The role of cystoid macular edema as a marker in the progression of non-paraneoplastic autoimmune retinopathy.
Finn AP; Thomas AS; Stinnett SS; Keenan RT; Grewal DS; Jaffe GJ
Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):1867-1873. PubMed ID: 30128606
[TBL] [Abstract][Full Text] [Related]
9. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
[TBL] [Abstract][Full Text] [Related]
10. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated retinopathy preceding the diagnosis of cancer.
Hoogewoud F; Butori P; Blanche P; Brézin AP
BMC Ophthalmol; 2018 Nov; 18(1):285. PubMed ID: 30390655
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
Adamus G; Ren G; Weleber RG
BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
[TBL] [Abstract][Full Text] [Related]
13. Clinical and immunological characterization of paraneoplastic retinopathy.
Makiyama Y; Kikuchi T; Otani A; Oishi A; Guo C; Nakagawa S; Ogino K; Kojima H; Kurimoto M; Yoshimura N
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5424-31. PubMed ID: 23860756
[TBL] [Abstract][Full Text] [Related]
14. Remission of nonparaneoplastic autoimmune retinopathy after minimal steroid treatment.
Bursztyn LL; Belrose JC; Coupland SG; Fraser JA; Proulx AA
Retin Cases Brief Rep; 2015; 9(2):173-6. PubMed ID: 25764315
[TBL] [Abstract][Full Text] [Related]
15. Outcomes in Autoimmune Retinopathy Patients Treated With Rituximab.
Davoudi S; Ebrahimiadib N; Yasa C; Sevgi DD; Roohipoor R; Papavasilieou E; Comander J; Sobrin L
Am J Ophthalmol; 2017 Aug; 180():124-132. PubMed ID: 28483493
[TBL] [Abstract][Full Text] [Related]
16. SD-OCT and autofluorescence characteristics of autoimmune retinopathy.
Pepple KL; Cusick M; Jaffe GJ; Mruthyunjaya P
Br J Ophthalmol; 2013 Feb; 97(2):139-44. PubMed ID: 23221966
[TBL] [Abstract][Full Text] [Related]
17. Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.
Benson MD; Plemel DJA; Yacyshyn E; Sandhu I; MacDonald IM; Baker CF
Ocul Immunol Inflamm; 2020 Aug; 28(6):958-965. PubMed ID: 31418623
[TBL] [Abstract][Full Text] [Related]
18. Acute zonal occult outer retinopathy: a long-term follow-up study.
Gass JD; Agarwal A; Scott IU
Am J Ophthalmol; 2002 Sep; 134(3):329-39. PubMed ID: 12208243
[TBL] [Abstract][Full Text] [Related]
19. Acute progressive paravascular placoid neuroretinopathy with negative-type electroretinography in paraneoplastic retinopathy.
Chen FK; Chew AL; Zhang D; Chen SC; Chelva E; Chandrasekera E; Koay EMH; Forrester J; McLenachan S
Doc Ophthalmol; 2017 Jun; 134(3):227-235. PubMed ID: 28382556
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune retinopathy with positive anti-recoverin antibodies not associated with neoplasms: Case report.
Oporto Caroca JI; Oporto Caroca J
Arch Soc Esp Oftalmol (Engl Ed); 2019 Nov; 94(11):540-544. PubMed ID: 31470998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
